2020-12-12 · Find the latest Earnings Report Date for Scopus BioPharma Inc. Common Stock (SCPS) at Nasdaq.com.

(NASDAQ: SCPS) Scopus BioPharma stock price per share is $7.54 today (as of Apr 16, 2021). What is Scopus BioPharma's Market Cap?

08:59 AM ET. Newly public Oriental Culture, Scopus BioPharma stocks more than triple ahead of the open MarketWatch. More Scopus BioPharma Inc () Stock Market info Recommendations: Buy or sell Scopus BioPharma stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Scopus BioPharma share forecasts, stock quote and buy / sell signals below.According to present data Scopus BioPharma's SCPS_old shares and potentially its market environment have been in a bullish cycle in the last Scopus BioPharma Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st.

Scopus biopharma stock

What is Scopus BioPharma's Market Cap? Webull offers SCOPUS BIOPHARMA INC. (SCPS) historical stock prices, in- depth market analysis, NASDAQ: SCPS real-time stock quote data, in-depth charts, The latest Scopus Biopharma Inc USD0.001 share price. View recent trades and share price information for Scopus Biopharma Inc USD0.001. Apr 2, 2021 A Scopus Biopharma Inc. investor sued it for stock theft in Delaware Chancery Court, claiming the gene therapy company has excluded “3.5 View Scopus Biopharma (scopusbiopharma.com) location in New York, United States , revenue, industry and description. Find related Stock Symbol: SCPS. Scopus BioPharma Inc. is based in NEW YORK. Stock Name, Country, Market Cap, PE Ratio.

Scopus BioPharma started at buy with $20 stock price target at Benchmark Feb. 16, 2021 at 6:28 a.m. ET by Tomi Kilgore Newly public Oriental Culture, Scopus BioPharma stocks more than triple ahead

Scopus BioPharma Announces Pricing of $9 Million Follow-On Public Offering. Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the pricing of a $9 million follow-on public offering. The offering consists of 1,000,000 shares of common stock at a public offering price of $9.00 per share.

2020-12-15 · NEW YORK, Dec. 15, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the pricing of its initial public offering.. The company's common stock is set to begin trading

The company’s IPO launched on Wednesday with shares priced at $5.50 each.

3-covid-19-vaccine-stocks-that-coul…/ Scopus Biopharma Inc. (SCPS) Stock Price, News, Quote & History - Yahoo Finance.
Rökförbud restauranger sverige år

Consensus. Sell Buy Stock quotes are provided by Factset, Scopus BioPharma (SCPS) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. 15/03/2021 08:29:13 1-888-992-3836 Free 2021-01-30 · Find the latest Scopus BioPharma Inc. (SCPS) stock quote, history, news and other vital information to help you with your stock trading and investing. Scopus BioPharma started at buy with $20 stock price target at Benchmark Feb. 16, 2021 at 6:28 a.m.

Consensus.
Hundens hus hundfrisör

betallosningar e handel
registerutdrag skatteverket privat
leba ekonomibyrå ab
bostadsprisernas utveckling i sverige
lindex återbetalning swish
övningsköra privat regler bil
koldioxidutsläppen i världen

Scopus Biopharma, Inc. is a biopharmaceutical company that develops transformational therapeutics targeting serious diseases with unmet medical needs. Its drug candidates comprises of combination of cannabidiol-mediated, opioid-sparing anesthetics, synthesis of cannabinoids, and cannabinoid receptor mediating compounds for the treatment of systemic sclerosis.

Its lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. The company is also developing 1 Wall Street analysts have issued 12-month target prices for Scopus BioPharma's stock.

Vetlanda larcentrum
johan nordahl mustad

Scopus BioPharma started at buy with $20 stock price target at Benchmark MarketWatch. Thursday, December 17, 2020. 04:22 PM ET. U.S. stock indexes clinch new record highs as bulls pin buying to fiscal spending bill MarketWatch. 08:59 AM ET. Newly public Oriental Culture, Scopus BioPharma stocks more than triple ahead of the open MarketWatch. More

Scopus BioPharma Inc. Common Stock (SCPS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Newly public Oriental Culture, Scopus BioPharma stocks more than triple ahead of the open Shares of Oriental Culture Holding Ltd. more than tripled (up 204.3%) in premarket trading Thursday, as the Hong Kong-based provider of collectibles and artwork e-commerce services heads for its third s 3 months ago - Market Watch A high-level overview of Scopus BioPharma Inc. (SCPS) stock.

Scopus Biopharma Inc. (SCPS): Price and Financial Metrics Recent IPO We have 9 different ratings for every stock to help you appreciate its future potential.

However, shares of the 2020-12-17 · Another IPO that is having a better second day that first day is Scopus BioPharma Inc. SCPS, +0.33% as the stock is also set to more-than triple Thursday (up 218.9% premarket).

The stock price of Scopus BioPharma (NASDAQ: SCPS) increased from $8.17 at 11 AM ET on December 16 to $33.96 on December 17 at 4 PM ET. Scopus BioPharma — which is a company that develops transformational therapeutics targeting serious diseases — had debuted on the Nasdaq on December 16. 2020-12-20 · View the latest Scopus BioPharma Inc. (SCPS) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-04-15 · Learn about SCPS (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our How volatile is Scopus BioPharma's share price compared to the market and industry in the last 5 years? Simply Wall St News. 1 month ago | Simply Wall St. Scopus Biopharma Inc. (SCPS): Price and Financial Metrics Recent IPO We have 9 different ratings for every stock to help you appreciate its future potential. Stockopedia rates Scopus Biopharma Inc as a Highly Speculative Sucker Stock .